{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:35:39Z","timestamp":1778920539047,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/igc.0b013e3182392714","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T08:55:10Z","timestamp":1327395310000},"page":"254-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Family History and Women With Ovarian Cancer:Is it Asked and Does it Matter?"],"prefix":"10.1016","volume":"22","author":[{"given":"Anne","family":"Lanceley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zara","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Ledermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Side","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182392714_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e3182392714_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","article-title":"Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family","volume":"8","author":"Evans","year":"2008","journal-title":"BMC Cancer."},{"key":"10.1097\/IGC.0b013e3182392714_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynaecological cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e3182392714_bb0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","article-title":"The contribution of BRCA1 and BRCA2 to ovarian cancer","volume":"3","author":"Ramus","year":"2009","journal-title":"Mol Oncol."},{"key":"10.1097\/IGC.0b013e3182392714_bb0025","unstructured":"Cancer Research UK. Inherited genes and cancer risk. Cancer Research UK Web site. February 2, 2011.Available at: http:\/\/www.cancerhelp.org.uk\/about-cancer\/ causes-symptoms\/genes-and-inherited-cancer-risk.Accessed May 5, 2011."},{"key":"10.1097\/IGC.0b013e3182392714_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ng.668","article-title":"Ovarian Cancer Association Consortium. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24","volume":"42","author":"Goode","year":"2010","journal-title":"Nat Genet."},{"key":"10.1097\/IGC.0b013e3182392714_bb0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e3182392714_bb0040","unstructured":"National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, Genetic\/Familial High-Risk Assessment: Breast and Ovarian Version 1.2011. 2011.Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/ f_guidelines.asp. Accessed June 16, 2011."},{"key":"10.1097\/IGC.0b013e3182392714_bb0045","unstructured":"National Institute of Clinical Excellence. CG41NICEguidance. NICE Web site. October 2006. Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG41NICEguidance.Accessed May 5, 2011."},{"key":"10.1097\/IGC.0b013e3182392714_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmg.2007.048991","article-title":"Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)","volume":"44","author":"Vasen","year":"2007","journal-title":"J Med Genet."},{"key":"10.1097\/IGC.0b013e3182392714_bb0055","unstructured":"National Institute for Clinical Excellence. Ovarian cancer: the recognition and initial management of ovarian cancer.April 2011. Available at: http:\/\/www.nice.org.uk\/guidance. Accessed April 30, 2011."},{"key":"10.1097\/IGC.0b013e3182392714_bb0060","unstructured":"National Genetics Education and Development Centre. May 10, 2011. Available at: http:\/\/www.geneticseducation.nhs.uk\/.Accessed May 23, 2011."},{"key":"10.1097\/IGC.0b013e3182392714_bb0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/fampra\/cmn053","article-title":"Interviews with primary care physicians regarding taking and interpreting the cancer family history","volume":"25","author":"Wood","year":"2008","journal-title":"Fam Pract."},{"key":"10.1097\/IGC.0b013e3182392714_bb0070","first-page":"817","article-title":"Evaluation of the impact of two educational interventions on GP management of familial breast\/ovarian cancer cases: a cluster randomised trial","volume":"51","author":"Wilson","year":"2001","journal-title":"Br J Gen Pract."},{"key":"10.1097\/IGC.0b013e3182392714_bb0075","first-page":"1480","article-title":"Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history","volume":"292","author":"Murff","year":"2010","journal-title":"J Am Med Soc."},{"key":"10.1097\/IGC.0b013e3182392714_bb0080","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.1979.03300120022017","article-title":"Family history in an oncology clinic. Implications for cancer genetics","volume":"242","author":"Lynch","year":"1979","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e3182392714_bb0085","series-title":"Our Inheritance, Our Future: Realising the Potential of Genetics in the NHS","author":"Department of Health","year":"2003"},{"key":"10.1097\/IGC.0b013e3182392714_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2008.06.016","article-title":"What women with ovarian cancer think and know about genetic testing","volume":"111","author":"Lacour","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182392714_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.2002.20.2.528","article-title":"Identification and referral of families at high risk for cancer susceptibility","volume":"20","author":"Sweet","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182392714_bb0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1463-1318.2006.01047.x","article-title":"Family and personal history in colorectal cancer patients: what are we missing?","volume":"8","author":"Alberto","year":"2005","journal-title":"Colorectal Dis."},{"key":"10.1097\/IGC.0b013e3182392714_bb0105","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet Gynaecol."},{"key":"10.1097\/IGC.0b013e3182392714_bb0110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10897-010-9308-y","article-title":"Exploring hereditary cancer among dying cancer patients-a cross-sectional study of hereditary risk and perceived awareness of DNA testing and banking","volume":"19","author":"Quillin","year":"2010","journal-title":"J Genet Couns."},{"issue":"121","key":"10.1097\/IGC.0b013e3182392714_bb0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"1","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182392714_bb0120","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","article-title":"BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark","volume":"14","author":"Soegaard","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e3182392714_bb0125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/GIM.0b013e3181ab2295","article-title":"Timing of BRCA1\/ BRCA2 genetic testing in women with ovarian cancer","volume":"11","author":"Daniels","year":"2009","journal-title":"Genet Med."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:03Z","timestamp":1753233183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24058353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1048891X24058353"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182392714","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Family History and Women With Ovarian Cancer:Is it Asked and Does it Matter?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182392714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}